# Amgen Inc. (AMGN) — Q4-2025 Earnings Results

**Report date:** 2026-02-03 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2025

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.77%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.29 | N/A | +11.18% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, indicating stronger-than-expected profitability. However, the stock reacted negatively, declining by 1.77%. The lack of revenue data and forward guidance may have contributed to investor uncertainty.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2025_